Imigran STATdose - Japan Clinical Experience Study for Self-injection

Next Previous
Trial Profile

Imigran STATdose - Japan Clinical Experience Study for Self-injection

Completed
Phase of Trial: Phase III

Latest Information Update: 24 Nov 2017

At a glance

  • Drugs Sumatriptan (Primary)
  • Indications Cluster headache; Migraine
  • Focus Therapeutic Use
  • Sponsors GlaxoSmithKline

    • Most Recent Events

    • 04 Apr 2008 Status changed from recruiting to completed according to ClinicalTrials.gov.
    • 01 Nov 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top